Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $6.0 million.

  • Cross Country Healthcare's Share-based Compensation fell 1195.4% to $766000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 2267.87%. This contributed to the annual value of $6.0 million for FY2024, which is 842.07% down from last year.
  • Latest data reveals that Cross Country Healthcare reported Share-based Compensation of $6.0 million as of FY2024, which was down 842.07% from $6.6 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Share-based Compensation peaked at $7.4 million during FY2022, and registered a low of $5.4 million during FY2020.
  • For the 5-year period, Cross Country Healthcare's Share-based Compensation averaged around $6.5 million, with its median value being $6.6 million (2023).
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 5909.89% in 2020, then crashed by 1101.04% in 2023.
  • Over the past 5 years, Cross Country Healthcare's Share-based Compensation (Annual) stood at $5.4 million in 2020, then grew by 27.6% to $6.9 million in 2021, then increased by 7.24% to $7.4 million in 2022, then decreased by 11.01% to $6.6 million in 2023, then dropped by 8.42% to $6.0 million in 2024.
  • Its Share-based Compensation stands at $6.0 million for FY2024, versus $6.6 million for FY2023 and $7.4 million for FY2022.